ARDT logo

Ardent HealthNYSE:ARDT Stock Report

Market Cap US$1.6b
Share Price
US$10.95
My Fair Value
US$20
45.9% undervalued intrinsic discount
1Y-33.8%
7D-24.4%
Portfolio Value
View

Ardent Health (ARDT) Stock Overview

Owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. More details

ARDT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends0/6

ARDT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Ardent Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ardent Health
Historical stock prices
Current Share PriceUS$10.95
52 Week HighUS$20.72
52 Week LowUS$10.90
Beta0
1 Month Change-16.03%
3 Month Change-7.28%
1 Year Change-33.84%
3 Year Changen/a
5 Year Changen/a
Change since IPO-31.82%

Recent News & Updates

author-image

Expanding Urban And Suburban Outpatient Access Will Fuel Future Demand

Expansion in outpatient care and partnerships, including acquisitions and joint ventures, is strengthening market position and diversifying revenue streams.

Is Ardent Health (NYSE:ARDT) Using Too Much Debt?

Jul 18
Is Ardent Health (NYSE:ARDT) Using Too Much Debt?

Ardent Health: The Best Prospect In An Industry That's Facing Challenges

Jul 17

Recent updates

author-image

Expanding Urban And Suburban Outpatient Access Will Fuel Future Demand

Expansion in outpatient care and partnerships, including acquisitions and joint ventures, is strengthening market position and diversifying revenue streams.

Is Ardent Health (NYSE:ARDT) Using Too Much Debt?

Jul 18
Is Ardent Health (NYSE:ARDT) Using Too Much Debt?

Ardent Health: The Best Prospect In An Industry That's Facing Challenges

Jul 17

Estimating The Fair Value Of Ardent Health Partners, Inc. (NYSE:ARDT)

Apr 16
Estimating The Fair Value Of Ardent Health Partners, Inc. (NYSE:ARDT)

Is Ardent Health Partners (NYSE:ARDT) Using Too Much Debt?

Feb 22
Is Ardent Health Partners (NYSE:ARDT) Using Too Much Debt?

Shareholder Returns

ARDTUS HealthcareUS Market
7D-24.4%-6.0%0.8%
1Y-33.8%-30.6%13.7%

Return vs Industry: ARDT underperformed the US Healthcare industry which returned -30.7% over the past year.

Return vs Market: ARDT underperformed the US Market which returned 14.8% over the past year.

Price Volatility

Is ARDT's price volatile compared to industry and market?
ARDT volatility
ARDT Average Weekly Movement6.8%
Healthcare Industry Average Movement6.7%
Market Average Movement6.3%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.1%

Stable Share Price: ARDT has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: ARDT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200122,050Marty Bonickwww.ardenthealth.com

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers.

Ardent Health, Inc. Fundamentals Summary

How do Ardent Health's earnings and revenue compare to its market cap?
ARDT fundamental statistics
Market capUS$1.59b
Earnings (TTM)US$224.68m
Revenue (TTM)US$6.02b
7.0x
P/E Ratio
0.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ARDT income statement (TTM)
RevenueUS$6.02b
Cost of RevenueUS$2.57b
Gross ProfitUS$3.45b
Other ExpensesUS$3.23b
EarningsUS$224.68m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.57
Gross Margin57.32%
Net Profit Margin3.73%
Debt/Equity Ratio69.5%

How did ARDT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/21 07:03
End of Day Share Price 2025/07/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ardent Health, Inc. is covered by 15 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin FischbeckBofA Global Research
Joanna Sylvia GajukBofA Global Research
Jason CassorlaCitigroup Inc